Studies show that in addition to targeting the above mentioned signaling pathways, anlotinib can directly inhibit the proliferation of tumor cells by inhibiting the proliferation of related receptors (c‐kit) and downstream signaling pathway, which has a dual antitumor effect.15 The gene discussed is KIT; the disease is neoplasm.